Novartis N1VS34 Income Statements

Conto economico

Quarter End	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	13,97B	12,95B	14,19B	6,87B	20,09B	11,83B	13,16B	12,17B
Reddito operativo	1,95B	2,86B	2,92B	1,41B	2,84B	3,34B	4,01B	3,62B
Reddito ante imposte	1,74B	2,74B	2,77B	1,24B	2,59B	3,13B	3,84B	3,39B
Reddito netto	1,47B	2,29B	2,32B	1,76B	8,48B	2,69B	3,25B	3,19B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	1,95B	2,86B	2,92B	1,41B	2,84B	3,34B	4,01B	3,62B
EBITDA	3,9B	4,85B	2,75B	6,27B	4,44B	4,66B	5,17B	5,59B

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	49,44B	50,14B	53,17B	50,49B	49,9B	52,88B	51,83B	54,11B
Reddito operativo	8,97B	9,74B	14,61B	9,82B	10,83B	27,03B	9,19B	10,02B
Reddito ante imposte	7,82B	9B	13,84B	9B	9,88B	26,14B	8,37B	9,33B
Reddito netto	6,71B	7,7B	12,61B	11,73B	8,07B	24,02B	6,96B	14,85B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	2.753	3.234	5.309	5.037	3.478	10.449	3.185	7.046
UTILE OPERATIVO	8,98B	9,75B	14,61B	9,82B	10,83B	27,03B	9,19B	10,02B
EBITDA	15,03B	15,85B	21,34B	15,68B	17,3B	33,24B	16,38B	18,31B